Skip to main content
. Author manuscript; available in PMC: 2014 Aug 20.
Published in final edited form as: Anticancer Res. 2010 Apr;30(4):1263–1272.

Figure 5.

Figure 5

Association of unique SNP in CD44 intron 1 (CD44 Ex2+14 A>G) and CD44 expression on peripheral blood mononuclear cells (PBMC) from healthy normal donors. Representative histogram of CD44 expression on PBMC from normal donors who: (A) did not have the unique SNP, (B) had heterozygous unique SNP, and (C) had homozygous unique SNP. PBMC from female healthy normal donors were stained with FITC-conjugated anti-human CD44 antibody and analyzed by flow cytometer. The percentages of CD44high and CD44low PBMC populations are shown. (D) Comparison of percentages of CD44high PBMC populations among normal donors who did not have the unique SNP, those having heterozygous unique SNP and those having homozygous unique SNP. (E) Comparison of mean fluorescence intensity of CD44 expression on PBMC among normal donors who did not have the unique SNP, and those having heterozygous or homozygous unique SNP. (F) Comparison of levels of CD44 expression on PBMC, as determined by real-time PCR assay, among normal donors who did not have the unique SNP, and those having heterozygous or homozygous unique SNP.